Supplemental oxygen maintained during and for 2 h after colon resection halves the incidence of nausea and vomiting. Whether supplemental oxygen restricted to the intraoperative period is sufficient remains unknown. Similarly, the relative efficacy of supplemental oxygen and ondansetron is unknown. We tested the hypothesis that intraoperative supplemental oxygen reduces the incidence of postoperative nausea and vomiting. Patients (n ϭ 240) undergoing gynecological laparoscopy were given a standardized isoflurane anesthetic. After induction, they were randomly assigned to the following three groups: routine oxygen administration with 30% oxygen, balance nitrogen (30% Oxygen group), supplemental oxygen administration with 80% oxygen, balance nitrogen (80% Oxygen group), and Ondansetron 8 mg (immediately after induction), combined with 30% oxygen, balance nitrogen (Ondansetron group). The overall incidence of nausea and/or vomiting during the initial 24 postoperative h was 44% in the patients assigned to 30% oxygen and 30% in the Ondansetron group, but only 22% in those given 80% oxygen. The incidence was thus halved by supplemental oxygen and was significantly less than with 30% oxygen. There were, however, no significant differences between the 30% oxygen and ondansetron groups, or between the ondansetron and 80% oxygen groups. We conclude that supplemental oxygen effectively prevents postoperative nausea and vomiting after gynecological laparoscopic surgery; furthermore, ondansetron is no more effective than supplemental oxygen. (Anesth Analg 2001;92:112-7) 
Supplemental oxygen maintained during and for 2 h after colon resection halves the incidence of nausea and vomiting. Whether supplemental oxygen restricted to the intraoperative period is sufficient remains unknown. Similarly, the relative efficacy of supplemental oxygen and ondansetron is unknown. We tested the hypothesis that intraoperative supplemental oxygen reduces the incidence of postoperative nausea and vomiting. Patients (n ϭ 240) undergoing gynecological laparoscopy were given a standardized isoflurane anesthetic. After induction, they were randomly assigned to the following three groups: routine oxygen administration with 30% oxygen, balance nitrogen (30% Oxygen group), supplemental oxygen administration with 80% oxygen, balance nitrogen (80% Oxygen group), and Ondansetron 8 mg (immediately after induction), combined with 30% oxygen, balance nitrogen (Ondansetron group). The overall incidence of nausea and/or vomiting during the initial 24 postoperative h was 44% in the patients assigned to 30% oxygen and 30% in the Ondansetron group, but only 22% in those given 80% oxygen. The incidence was thus halved by supplemental oxygen and was significantly less than with 30% oxygen. There were, however, no significant differences between the 30% oxygen and ondansetron groups, or between the ondansetron and 80% oxygen groups. We conclude that supplemental oxygen effectively prevents postoperative nausea and vomiting after gynecological laparoscopic surgery; furthermore, ondansetron is no more effective than supplemental oxygen. N ausea and vomiting are unpleasant for patients; furthermore, they may increase the risk of aspiration pneumonia. Nausea and vomiting are also costly, being the leading cause of unexpected admission after planned day surgery (1) .
The incidence of postoperative nausea and vomiting (PONV) depends on numerous nonanesthetic factors, including age, gender, obesity, anxiety, gastroparesis, history of motion sickness, previous PONV, and the duration and type of surgery. Anesthesia-related factors include premedication, ventilation techniques, and postoperative pain management (2) (3) (4) .
An additional anesthetic factor that influences the incidence of PONV is the inspired oxygen concentration. For example, the incidence of nausea and vomiting was reduced by a factor of two in patients given 80% rather than 30% inspired oxygen during surgery and for 2 h postoperatively (5) . That perioperative oxygen proved an effective treatment was surprising, because the peak incidence of nausea and vomiting occurred well after supplemental oxygen was discontinued.
The efficacy of oxygen may be related to ameliorating subtle intestinal ischemia with its consequent release of emetogenic substances, including serotonin. Intestinal ischemia seems more likely during surgery than postoperatively because that is when the bowel is manipulated and compressed by retractors. To the extent that this theory is correct, intraoperative oxygen presumably contributed more to reducing the incidence of PONV than the 2 h of postoperative oxygen.
Selective 5-hydroxytryptamin 3 (5-HT 3 , serotonin) receptor antagonists are effective for preventing and treating PONV (3, 6) . Ondansetron is either more effective or as effective as other antiemetics such as metoclopramide, promethazine, or droperidol (7) (8) (9) (10) . We therefore tested the hypothesis that supplemental oxygen restricted to the intraoperative period reduces the incidence of PONV, and that the reduction is comparable to that produced by 8 mg of ondansetron.
Methods
With approval of the IRB at the University of Vienna and written informed consent, we studied patients undergoing gynecological laparoscopy with an expected surgical duration exceeding 1 h and anticipated overnight hospitalization. Sample size for this study was based on the observed incidence of PONV during a 3-mo preliminary study in laparoscopy patients. These data indicated that 216 patients would provide a 90% power for detecting a 50% reduction in nausea and vomiting (from 45% to 22%) with each treatment at an ␣ level of 0.05. We therefore prospectively set the sample size at 240 patients, divided equally among three groups.
The study was restricted to patients aged from 19 to 70 yr who were ASA physical status I-II. The exclusion criteria were pregnancy, breast-feeding, menopausal status, obesity (Ͼ150% normal weight), eating disorder, renal or liver malfunction, central nervous system injury, vertebrobasilar artery insufficiency, vestibular disease, cytostatic therapy, and preoperative vomiting or antiemetic therapy.
Patients were premedicated with 7.5 mg oral midazolam on the morning of surgery. Anesthesia was induced with sodium thiopental (3-5 mg/kg), vecuronium bromide (0.1 mg/kg), and fentanyl citrate (1-3 g/kg). Anesthesia was subsequently maintained with isoflurane (1.2-1.8%) in the carrier gas described below. A gastric tube was positioned, left on low suction throughout surgery, and then removed just before the end of anesthesia.
After induction of anesthesia, patients were randomly assigned to the following three groups: routine oxygen administration with 30% oxygen, balance nitrogen, not nitrous oxide (30% Oxygen group), supplemental oxygen administration with 80% oxygen, balance nitrogen (80% Oxygen group), and Ondansetron 8 mg IV immediately after induction of anesthesia, combined with 30% oxygen, balance nitrogen (Ondansetron group). The computer-generated assignments were kept in sealed envelopes until used. Patients were not informed of their group assignments. Investigator blinding was maintained by providing separate teams to manage the intraoperative and postoperative aspects of the study.
Isoflurane administration was adjusted by the attending anesthesiologist with the goal of maintaining arterial blood pressure within 20% of preinduction values. Mechanical ventilation was controlled to maintain end-tidal carbon dioxide tension near 35 mm Hg. Forced-air warming was used as necessary to keep distal esophageal temperature near 36°C. Neuromuscular relaxation was antagonized at the end of surgery with 2.5 mg neostigmine and 0.4 mg glycopyrrolate. Crystalloids were administered at a rate of 15 mL ⅐ kg Ϫ1 ⅐ h Ϫ1 throughout surgery.
Intraoperative administration of the study gas continued until immediately before tracheal extubation and was then increased to 100% oxygen for extubation. During postanesthetic recovery, oxygen was given to all patients via face masks for 2 h at a rate of 2 L/min. The patients subsequently breathed room air as tolerated (Sao 2 Ն 92%).
The anesthesiologists were not blinded as to group assignment. However, patients, surgeons, and the nurses reporting PONV were blinded as to group assignments and intraoperative management. To this end, cardboard shields were positioned over the flowmeters on the anesthetic machine. Irrespective of group assignment, oxygen was administered as necessary to maintain intraoperative oxyhemoglobin saturation (Sao 2 ) 95% in all patients. Ondansetron 4 mg, as a rescue medication, was given in cases where nausea persisted for more than 15-20 min or vomiting was observed.
Morphometric and demographic characteristics of each treatment group were recorded. Historical factors likely to influence PONV were recorded. These factors included previous PONV, smoking history, preoperative hemoglobin, coexisting systemic diseases, and substantial alcohol use (more than two drinks/day).
Hemodynamic responses, oxygen saturation, endtidal Pco 2 and anesthetic concentrations, inspired oxygen concentration (Fio 2 ), and esophageal temperature were measured during anesthesia at 15-min intervals. In the postanesthesia care unit (PACU), hemodynamic responses and oxygen saturation were recorded at 30-min intervals. Nausea and vomiting incidence and severity were determined by blinded observers at intervals over a 24-h period starting at arrival in the postoperative care unit. Nausea and vomiting were evaluated from 0 to 6 h and from 6 to 24 h postoperatively. Patients were asked to rate nausea on a four-point scale as none, mild, moderate, or severe.
The amount of rescue medication and postoperative pain therapy were recorded. Time to oral intake, time to discharge from recovery room and discharge home, and patient satisfaction were also recorded (11) .
Twenty-four hours after surgery, patient function was evaluated by the MOS 36-item Short-Form health survey (SF-36) (12) . Additionally, the patients' overall satisfaction with their anesthetic management was evaluated by asking if they would choose the same type of anesthesia for a future surgery.
Our primary, prospectively defined outcome was the incidence of nausea and/or vomiting over the initial 24 postoperative hours. The incidence of nausea and vomiting and potential confounding factors were evaluated by both univariate and multivariate statistics. One-way analysis of variance and 2 analyses were used for the univariate analyses. End-tidal isoflurane and Pco 2 , fentanyl dose, fluid volume, Spo 2 , and intraoperative mean arterial pressure were first averaged over the anesthetic period in each patient. Subsequently, these values were averaged among the patients in each group.
Nausea severity was evaluated with Kruskal-Wallis tests. The incidence of nausea and combined nausea and vomiting (PONV) were compared by 2 analyses. For the combined nausea and vomiting analysis, any score for nausea or vomiting exceeding "none" was considered positive. Finally, we used a multivariate regression to evaluate the contributions of potential confounding factors on the combined incidence of nausea and vomiting. Potential confounding factors that were entered into this regression included motion sickness, nausea-vomiting history, alcohol intake, and smoking.
Results are presented as means Ϯ sd, percentages, or odds ratios and 95% confidence intervals. P Ͻ 0.05 was considered statistically significant.
Results
Morphometric and demographic factors, hemodynamic responses, and anesthetic management, including intraoperative fluid regimen and duration of anesthesia, were comparable in all three groups (Table  1) . Potential confounding factors, including smoking history, alcohol intake, history of motion sickness and PONV, were also comparable in the three treatment groups. Overall postoperative pain scores were slightly larger in the 30% oxygen group than in the patients given 80% oxygen.
Nausea and vomiting was worst in the first 6 h postoperatively, and subsequently decreased in all three groups. The overall incidence of nausea and vomiting during the initial 24 postoperative hours was 44% in the patients assigned to 30% oxygen, 30% in the ondansetron group, but only 22% in those given 80% oxygen. The difference between 30% and 80% oxygen was statistically significant. There were, however, no statistically significant differences between the 30% oxygen and ondansetron groups, or between the ondansetron and 80% oxygen groups ( Table 2) .
The difference in the incidence of PONV in the 30% and 80% oxygen groups was confirmed by multivariate analysis that included the effects of potential confounding factors such as history of motion sickness, nausea and vomiting, smoking, or alcohol intake (Table 3) .
Patients in each of the three treatment groups began liquid and solid food at similar times, and were discharged from the PACU and hospital at similar times. SF-36 physical function and mental status scores 24 h after surgery were comparable in each treatment group, as was willingness to have the same anesthetic for a future surgery.
Discussion
Our previous study demonstrated that 80% oxygen during and for two hours after colon resection reduces the incidence of PONV by a factor of two (5) . This result is surprising because there is no established mechanism by which oxygen given only during and shortly after surgery influences nausea and vomiting many hours after patients leave the PACU. Our current results nonetheless confirm the previous ones, suggesting that they did not result simply from a statistical fluke or inadequate control of confounding factors.
Our current results also extend our initial findings by showing that supplemental oxygen is effective even when restricted to the intraoperative period, rather than being continued for two postoperative hours. Neither study directly compared supplemental intraoperative oxygen with the combination of intraoperative and postoperative oxygen. However, each provided a strikingly similar two-fold reduction in nausea and vomiting. These data suggest that supplemental postoperative oxygen is less important than intraoperative administration.
Patients participating in this study presumably experienced little vestibulocochlear stimulation, and there is no reason to assume that oxygen administration reduced nausea and vomiting by influencing this region. Hyperoxia decreases dopamine release by the carotid bodies (13) . This is potentially important because the chemotactic trigger zone is sensitive to dopamine as well as serotonin (14) . Hyperoxia per se may thus reduce nausea and vomiting mediated by dopamine. However, any effect on this region would presumably apply only during oxygen administration. It therefore seems unlikely that an action at the chemoreceptor trigger zone reduced nausea and vomiting many hours after oxygen administration ceased.
Intestinal tissue is highly metabolically active and has a notoriously poor tolerance for even brief periods of hypoxia or ischemia (15) . An important intestinal response to ischemia is release of serotonin (16)-a highly emetogenic substance. Supplemental oxygen may thus reduce PONV by ameliorating subtle intestinal ischemia, thereby reducing release of emetogenic substances from compromised bowel.
Colon resection is surely associated with at least some intestinal ischemia because perfusion is reduced by gut manipulation, especially when retractors distort the normal gut configuration. Insufflation of the Data are presented as means Ϯ sd and percentages. There were no significant differences between the patients given ondansetron and the other two groups. VAS ϭ visual analog scale. a Statistically significant between the 80% Oxygen and 30% Oxygen groups. Rescue ondansetron was averaged only among patients who were given the drug. Consequently, only the fraction of patients given ondansetron was analyzed statistically. Data are presented as absolute values, percentages, or means Ϯ sd. There were no significant differences between the patients given ondansetron and the other two groups. a Statistically significant difference between the 80% Oxygen and 30% Oxygen groups.
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abdomen during laparoscopy significantly increases peritoneal pressure and thus also reduces intestinal blood flow (17, 18) . Patients undergoing colon resection or laparoscopy are thus similarly subject to subtle intestinal ischemia that supplemental oxygen might ameliorate.
The conventional method of preventing PONV is administration of 5-HT 3 antagonists. However, these drugs are quite expensive and cause occasional complications (19) . In contrast, 80% perioperative oxygen is not associated with clinically important complications, including atelectasis (20) . Oxygen is also remarkably inexpensive, costing only a few cents per patient. Oxygen thus seems preferable to 5-HT 3 antagonists for prevention of PONV.
Although supplemental intraoperative oxygen produced a statistically significant and clinically important reduction in PONV, there were no differences in longer-term outcomes. Patients in each of the three treatment groups had comparable physical function and mental status scores 24 hours after surgery and were equally willing to have the same anesthetic for future surgery. These data suggest that PONV did not have any serious or long-term impact on our patients. Our patients began liquid and solid food and were discharged from the PACU and hospital at similar times. We note that all these patients remained in the hospital for at least 24 hours after minor laparoscopy per local policy, not because hospitalization was medically required.
In planning our study, we assumed that efficacy of the two treatment groups (oxygen and ondansetron) would be comparable. That is, that each would reduce the incidence of PONV by a factor of two. This assumption seemed reasonable because numerous publications support this degree of efficacy for ondansetron (4, 6, 8, 21) and because our previous study demonstrated supplemental oxygen reduced the risk of PONV by a factor of two (5) . Had this assumption been confirmed, our study would have been adequately powered.
However, the actual efficacy of ondansetron proved to be much less than expected. We were therefore easily able to demonstrate that supplemental oxygen was effective, but failed to statistically distinguish ondansetron from either the control or oxygen groups.
Increasing our sample size to 1000 would presumably provide sufficient statistical power to statistically distinguish among all three groups. However, there are several compelling reason not to pursue this course. The first is that the sample size was prospectively determined based on reasonable estimates of treatment effect. It would be inappropriate to extend the study. The second issue is that it does not really matter whether ondansetron is as good as oxygen: the important point is that it clearly is not superior to oxygen.
We used 8 mg of ondansetron, which is twice the usual dose. However, this dose has been used in a number of previous studies (22, 23, 24) . We used this large dose to forestall the conclusion that ondansetron might have been more effective than oxygen had we given a larger dose.
In summary, 80% intraoperative oxygen halved the incidence of PONV in gynecological laparoscopic surgery. Prophylactic administration of 8 mg ondansetron also somewhat reduced the incidence of nausea and vomiting, but by an amount that did not differ significantly from 30% oxygen or from 80% oxygen. Because supplemental oxygen is inexpensive and essentially risk-free, it appears preferable to pharmacologic antiemetics. History of motion sickness, of nausea and vomiting, of smoking, and of alcohol intake were entered in the multivariate analysis.
